Senior Epidemiological Programmer, Real World Evidence - FSP
IQVIA
Summary
IQVIA is hiring to expand our dedicated Real World Evidence (RWE) FSP team, working fully within the environment of a prominent Pharma company. The Epidemiological Programmer role sits within our Real World Solutions team and will be responsible for leading development of datasets and conducting longitudinal analyses for observational studies in the virology therapeutic area under one client portfolio.
Job description
Essential Functions
- Lead development of analytic datasets through raw data processing and conduct data checks / cleaning using secondary real world data sources, including claims, EHR, and lab data (e.g. Optum, HealthVerity, TriNetX, IQVIA PharMetrics Plus)
- Lead the feasibility of real-world data sources to characterize patient population, build patient cohorts, and define and validate key variables specific to study objectives
- Conduct and QC analyses, including identification of diagnosis and treatment codes and applying statistical methods to handle censored data, confounding, differing person-time, and missing data
- Collaborate with epidemiologists on study design and methodology, as well as define specifications for descriptive and complex statistics (e.g. longitudinal analysis, survival analysis, regression models, propensity score methods) in studies using RWD for virology research questions
- Develop and QC TFLs for protocols/reports/manuscripts using RWD (e.g. claims and EHR)
- Support development of other study documents including protocols, statistical analysis plans, and study reports
- Communicate timelines, progress reports, and results to project team and key stakeholders
- Provide technical, programming, statistical, and epidemiological expertise and independently bring project solutions to team for complex studies
Qualifications
- Master's Degree in Biostatistics, Epidemiology, Outcomes Research or related field with 5-8 years relevant experience or PhD with 3 years relevant experience required
- Strong track record of analysis of RWD using EMR and claims data
- Demonstrated proficiency in advanced statistical programming using SAS and/or R, macros, SQL required
- Demonstrated experience and applied proficiency of RWE study design, terminology, cohort building, and analytic methodologies
- Prior pharmaceutical or CRO experience
- Excellent analytic and communication skills with attention to detail
- Ability to effectively manage and prioritize multiple tasks and projects
Requirements
- Master's Degree in Biostatistics, Epidemiology, Outcomes Research or related field with 5-8 years relevant experience or PhD with 3 years relevant experience
- Strong track record of analysis of RWD using EMR and claims data
- Demonstrated proficiency in advanced statistical programming using SAS and/or R, macros, SQL
- Demonstrated experience and applied proficiency of RWE study design, terminology, cohort building, and analytic methodologies
- Prior pharmaceutical or CRO experience
- Excellent analytic and communication skills with attention to detail
- Ability to effectively manage and prioritize multiple tasks and projects
Benefits
- Health and Welfare Benefits
- Incentive Plans
- Bonuses
Company overview
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Headquartered in Durham, North Carolina, the company operates in over 100 countries with approximately 86,000 employees worldwide. IQVIA specializes in creating intelligent connections across all aspects of healthcare through its proprietary IQVIA Connected Intelligence platform, which combines analytics, transformative technology, big data resources, and extensive domain expertise. The company's comprehensive portfolio includes clinical trial management, real-world evidence generation, commercial insights, and regulatory compliance services. IQVIA serves a diverse client base including pharmaceutical manufacturers, biotechnology companies, medical device firms, government agencies, and healthcare providers. With its Healthcare-grade AI capabilities and extensive global data assets, IQVIA accelerates the development and commercialization of innovative medical treatments while improving healthcare outcomes for patients globally. The company is publicly traded on the New York Stock Exchange under the ticker symbol IQV.